After an initial year of pilot collaboration, the AFM is extending its partnership with Myosix, which is specialized in the production and development of cell therapy products, for the free provision of myoblasts to research teams working to develop therapies for neuromuscular diseases: 12 teams in France and abroad have already benefited from this service, with a provision of 88 batches of myoblasts. The myoblasts used were tissue extracts from healthy volunteers or patients with certain dystrophies (FSH, DMD, DM1, ...) from the collections of the Research Tissue Bank (Myobank-AFM, Institute of Myology).
Références :